Specialty Overview

Best Hospitals for Myocardial Infarction Treatment in Mumbai, India

17 cardiothoracic & vascular surgery hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the cardiothoracic & vascular surgery hospitals in our directory offering Myocardial Infarction Treatment in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Ask us about myocardial infarction treatment in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 17 accredited hospitals for Cardiothoracic & Vascular Surgery in Mumbai, India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering myocardial infarction treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering myocardial infarction treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering myocardial infarction treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by JCI, NABH

Patients considering myocardial infarction treatment can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviewsAccredited by JCI, NABH638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering myocardial infarction treatment can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviewsAccredited by JCI, NABH326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering myocardial infarction treatment can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviewsAccredited by NABH, NABL350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Accredited by NABH, NABL

Patients considering myocardial infarction treatment can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviewsAccredited by NABH, JCI450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Accredited by NABH, JCI

Patients considering myocardial infarction treatment can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviewsAccredited by NABH310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Accredited by NABH

Patients considering myocardial infarction treatment can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by NABH

Patients considering myocardial infarction treatment can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing myocardial infarction treatment.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cardiothoracic & Vascular Surgery is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Myocardial Infarction Treatment in Mumbai, India?

Choosing the right hospital for myocardial infarction treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cardiothoracic & vascular surgery rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Myocardial Infarction Treatment

Myocardial infarction (heart attack) treatment encompasses emergency reperfusion therapy, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and intensive post-infarct medical management — a spectrum of care where timing, technology, and surgical volume directly determine survival and long-term cardiac function.

5–14 days (varies by intervention: primary PCI typically 3–5 days ICU + step-down; surgical CABG typically 7–14 days total)
Hospital Stay
2–6 weeks (primary PCI patients: approximately 2–3 weeks; post-CABG patients: 4–6 weeks, subject to cardiologist clearance and absence of complications)
Total Stay in Country (Fit-to-Fly)
Primary PCI TIMI 3 flow restoration: >90%; In-hospital survival post-primary PCI: >95%; 30-day MACE-free survival in high-volume centres: ~93–96%
Success Rate

Clinical Overview

  • Myocardial infarction (MI) occurs when sustained ischaemia — most commonly caused by the rupture of a vulnerable atherosclerotic plaque and subsequent thrombotic occlusion of a coronary artery — results in irreversible cardiomyocyte necrosis.
  • The two principal clinical syndromes are ST-elevation MI (STEMI), characterised by complete occlusion and immediate reperfusion emergency, and non-ST-elevation MI (NSTEMI), managed along a risk-stratified pathway using validated scoring tools such as the GRACE (Global Registry of Acute Coronary Events) score and the TIMI Risk Score.
  • The extent of myocardial damage is quantified by peak troponin I or troponin T elevation, creatine kinase-MB fraction, and serial 12-lead ECG evolution, while left ventricular ejection fraction (LVEF) measured by transthoracic echocardiography (TTE) or cardiac MRI at 48–72 hours defines functional prognosis.
Full details →

Who is a Candidate?

  • ELIGIBILITY FOR PRIMARY PCI (STEMI): Patients presenting with ≥1 mm ST elevation in ≥2 contiguous leads or new left bundle branch block (LBBB) within 12 hours of symptom onset; symptom onset up to 24 hours in select haemodynamically unstable patients.
  • ELIGIBILITY FOR URGENT/EARLY INVASIVE STRATEGY (NSTEMI/UA): High-risk NSTEMI defined by GRACE score >140, recurrent ischaemia, dynamic ST changes, elevated troponin, LVEF <40%, haemodynamic instability, or sustained ventricular arrhythmias — requiring coronary angiography within 2–24 hours.
  • ELIGIBILITY FOR CABG POST-MI: Three-vessel or left main coronary artery disease (SYNTAX Score >33), diabetes with multi-vessel disease, failed PCI, or mechanical MI complications (VSR, papillary muscle rupture).
  • ELIGIBILITY FOR MEDICAL MANAGEMENT / SECONDARY PREVENTION (STABLE POST-MI): Patients with non-obstructive CAD, contraindications to intervention, patient preference, or those already revascularised requiring optimised pharmacotherapy and cardiac rehabilitation.
  • +2 more

Treatment Options & Approaches

  • REPERFUSION STRATEGIES:

Recovery

  • PHASE 1 — EMERGENCY PRESENTATION AND TRIAGE (Hours 0–2) The patient arrives at the emergency department or is transported by ambulance.
  • A 12-lead ECG is obtained and interpreted within 10 minutes of first medical contact.
  • High-sensitivity troponin is drawn.

Risks to be aware of

  • Myocardial infarction treatment carries procedure-specific and condition-specific risks that every patient must understand before travel and intervention.
  • For primary PCI: vascular access-site complications (haematoma, radial artery occlusion in ~2–5%; major bleeding in <1% with radial approach), contrast-induced acute kidney injury (risk elevated with pre-existing CKD, diabetes, or dehydration — mitigated by pre-hydration and minimised contrast volume), coronary artery dissection or perforation (<0.5%), stent thrombosis (acute: <1% with modern DES and adequate DAPT), and no-reflow phenomenon (microvascular obstruction despite epicardial vessel patency, occurring in 5–10% of STEMI PCI, associated with worse outcomes).
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive end-to-end medical travel coordination, recognising that a cardiac patient travelling internationally requires seamless non-medical infrastructure as much as clinical excellence.

Common questions about Myocardial Infarction Treatment

What is the cost of Myocardial Infarction Treatment in India versus the UAE?
The total cost of myocardial infarction treatment depends on the specific intervention required. In India, primary PCI (emergency angioplasty with drug-eluting stent) typically costs between USD 4,000 and USD 8,000, while coronary artery bypass grafting (CABG) for multi-vessel disease ranges from USD 8,000 to USD 18,000 — inclusive of surgical fees, cardiac ICU stay, drug-eluting stents, standard medications, and anaesthesiology. In the UAE (Dubai or Abu Dhabi), the same interventions cost between USD 9,000 and USD 16,000 for PCI and USD 18,000 to USD 35,000 for CABG, reflecting higher hospital infrastructure costs, premium nursing ratios, and luxury accommodation standards. Both destinations offer JCI-accredited hospitals with internationally trained interventional cardiologists. India is typically 40–60% more affordable for equivalent clinical quality and is the preferred destination for patients prioritising cost. The UAE is preferred for patients in the Middle East, Africa, or Europe seeking shorter travel and premium facilities. GAF Healthcare provides a detailed, itemised cost estimate for your specific case — including stent type, number of vessels, ICU duration, and haemodynamic support requirements — before any financial commitment is made.
How long do I need to stay in India or the UAE before I am fit to fly home after Myocardial Infarction Treatment?
The minimum in-country stay before you are medically cleared for an international flight depends on the intervention you received and your recovery trajectory. For uncomplicated primary PCI (angioplasty with stent) for STEMI or NSTEMI: most patients are fit to fly within 2–3 weeks of the procedure, provided the treating cardiologist confirms stable LVEF (ideally >45%), no significant arrhythmias on Holter or telemetry, controlled blood pressure, and no active bleeding on dual antiplatelet therapy. Short-haul flights (under 3 hours) may be cleared slightly earlier; long-haul flights (over 6 hours) require more conservative assessment due to cabin hypoxia and deep vein thrombosis risk. For coronary artery bypass grafting (CABG): a minimum of 4–6 weeks in-country is required. Sternal healing must be confirmed by clinical assessment. Patients must be ambulatory, haemodynamically stable, free of pleural effusion or pericardial effusion requiring drainage, and tolerating full oral GDMT. A formal fit-to-fly assessment — including resting ECG, blood pressure, oxygen saturation, and wound inspection — is conducted by the treating cardiologist at the GAF Healthcare-coordinated pre-departure review. Airline medical clearance documentation (MEDIF/FREMEC) is prepared where required. Patients with post-MI complications (reduced LVEF <35%, persistent arrhythmia, cardiogenic shock requiring support) will have individual assessment with potentially longer stays.
What is the success rate of Myocardial Infarction Treatment at GAF Healthcare partner hospitals in India and the UAE?
At GAF Healthcare's partner JCI-accredited cardiac centres in India and the UAE, outcomes for myocardial infarction treatment benchmark against the world's leading institutions. For primary PCI in STEMI: TIMI 3 flow restoration (complete reperfusion) is achieved in over 90% of cases; in-hospital survival exceeds 95% for haemodynamically stable presentations (Killip Class I–II); 30-day major adverse cardiovascular event (MACE)-free survival — freedom from recurrent MI, stroke, and cardiovascular death — is approximately 93–96% at high-volume centres. For CABG: operative mortality for elective CABG in low-to-intermediate surgical risk patients (EuroSCORE II <3%) is below 1.5% at partner centres; 5-year freedom from repeat revascularisation exceeds 85% with arterial grafting (LIMA-to-LAD). Long-term outcomes are critically dependent on adherence to guideline-directed medical therapy (GDMT) post-discharge. Patients who maintain target LDL-C below 55 mg/dL, complete cardiac rehabilitation, and adhere to DAPT for 12 months reduce their 5-year risk of recurrent MI by approximately 40–50% compared to those without optimised therapy. It is important to understand that success rates vary by individual risk profile — age, LVEF at presentation, time-to-treatment, comorbidities, and infarct territory — and GAF Healthcare's partner cardiologists provide individualised risk stratification before travel.

How GAF Healthcare Assists in Choosing the Best Hospital for Myocardial Infarction Treatment in Mumbai, India

Discover the Top Hospitals for Myocardial Infarction Treatment in Mumbai, India

This page lists 17 accredited cardiothoracic & vascular surgery hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about myocardial infarction treatment in Mumbai, India

How many cardiothoracic & vascular surgery hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for cardiothoracic & vascular surgery including Myocardial Infarction Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cardiothoracic & Vascular Surgery is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cardiothoracic & vascular surgery hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for myocardial infarction treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about myocardial infarction treatment in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for myocardial infarction treatment in Mumbai, India.

Contact us to report an inaccuracy on this page.